Pacific Century Group

PropertyGuru Delivers over S$100m Revenue in 2021, Beats Full Year Forecast

Retrieved on: 
Monday, February 28, 2022
Data Management, Residential Building & Real Estate, Other Technology, Technology, Construction & Property, Award, Risk, Failure, CRIMINAL, COVID-19, Form, Publication, Solution, Prospectus, Growth, Pacific Century Group, Sale, SimilarWeb, Person, Securities Act of 1933, COVID, Insurance, Urbanization, NASDAQ, PIPE, LinkedIn, Forward-looking statement, YTD, Communication, THE, Tax, Pub, Industry, NYSE, Acquisition, Business architecture, EGM, Marketing, EBITDA, SEC, Animal, Security (finance), Risk management, Group

PropertyGuru Group (PropertyGuru or the Group), Southeast Asias leading1, property technology (PropTech) company today provided highlights of its full year 2021 performance.

Key Points: 
  • PropertyGuru Group (PropertyGuru or the Group), Southeast Asias leading1, property technology (PropTech) company today provided highlights of its full year 2021 performance.
  • Total revenue increased by 22.7% to S$100.7 million from S$82.1 million, reflecting rising confidence in the property market.
  • Hari V. Krishnan, Chief Executive Officer and Managing Director, PropertyGuru, said, Despite the uneven recovery from COVID-19 across Southeast Asia, PropertyGuru continued to execute well in 2021 delivering strong financial results.
  • 2 As disclosed in PropertyGuru Group Limiteds prospectus dated February 14, 2022
    4 Based on SimilarWeb data between January 2021 and June 2021.

22nd Century and KeyGene Achieve Breakthrough in Hemp/Cannabis Plant Transformation

Retrieved on: 
Wednesday, February 23, 2022
GLOBE, Risk, Nicotine, Health, Plant, Death, Corteva, Mutagenesis, Genetic engineering, Cannabis, CRISPR, Media, Gene, Research, Disease resistance, Keygen, Genome, Company, Pacific Century Group, Smoking, Regeneration, XXII, Disease, Gene editing, Century, DNA, Machine learning, Science, Tobacco, MRTP, RNC, Cannabinoid, FDA, IP, Nasdaq, Forward-looking statement, Enzyme, AI, Technology, Patent, Soybean, Solution, Breeding, Research and development, Time, Agriculture, Drug, Fine chemical, Syngenta

The plant transformation breakthrough unlocked by 22nd Century and KeyGene enables the desired DNA sequences to be inserted directly into or created from a plants existing genetic material, creating a more expedient and focused methodology to achieve the desired outcome.

Key Points: 
  • The plant transformation breakthrough unlocked by 22nd Century and KeyGene enables the desired DNA sequences to be inserted directly into or created from a plants existing genetic material, creating a more expedient and focused methodology to achieve the desired outcome.
  • Plant transformation is a means of inserting highly targeted DNA controlling desirable traits from one organism, typically another plant, into the genome of a high-value target crop.
  • The breakthrough gene editing and transformation technology will allow 22nd Century Group to target specific hemp/cannabis biosynthesis pathways and expand the ability to engineer the modification of cannabinoids in plants.
  • 22nd Century Group, Inc. (Nasdaq: XXII ) is a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science.

22nd Century Secures USDA Organic Certification for Needle Rock Farms

Retrieved on: 
Thursday, February 10, 2022
Health, Nicotine, Time, Smoking, Company, Title 21 CFR Part 11, Forward-looking statement, Solution, Death, Biomass, Pacific Century Group, Nasdaq, GLOBE, XXII, MRTP, RNC, FDA, Cannabinoid, Disease, Plant, CFR, Genetic engineering, Tobacco, Century, Drug, Medicinal plants

BUFFALO, N.Y., Feb. 10, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through modern plant science, announced today that is has received USDA Organic Certification under 7 CFR Part 205 for its hemp production at Needle Rock Farms.

Key Points: 
  • BUFFALO, N.Y., Feb. 10, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through modern plant science, announced today that is has received USDA Organic Certification under 7 CFR Part 205 for its hemp production at Needle Rock Farms.
  • USDA Organic Certification will allow 22nd Century to command a premium price and margin for its hemp biomass.
  • Organic certification is a valuable asset that enables premium pricing for the biomass grown at our Needle Rock Farms location.
  • 22nd Century Group, Inc. (Nasdaq: XXII ) is a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science.

Bridgetown 2 Holdings Limited (NASDAQ: BTNB) Announces Effectiveness of Registration Statement and Extraordinary General Meeting Date for Proposed Business Combination with PropertyGuru

Retrieved on: 
Tuesday, February 15, 2022
Commercial Building & Real Estate, Software, Construction & Property, Data Management, Technology, Other Construction & Property, Other Technology, Residential Building & Real Estate, Prospectus, Extraordinary general meeting, Pub, Technology, U.S. Securities and Exchange Commission, Person, Acquisition, COVID-19, SEC, Peter Thiel, West Avenue, Securities Act of 1933, Sale, Continental, Industry, SimilarWeb, NASDAQ, I&M Holdings Limited, Proxy, Risk, Registration statement, Google Analytics, THE, Register, Pacific Century Group, Publication, Communication, Property technology, Tax, PIPE, NYSE, Form, Business architecture, CRIMINAL, Forward-looking statement, Solution, Insurance, Failure, Growth, Multimedia, Auction, Security (finance), Risk management, Award, Group, PropertyGuru Group, Bridgetown 2, PROPERTYGURU GROUP, BRIDGETOWN 2

Bridgetown 2 recommends its shareholders vote in favor of the proposed business combination and the related proposals described in the Companys definitive proxy statement dated February 14, 2022 contained in the Registration Statement (the Proxy Statement), at Bridgetown 2s Extraordinary General Meeting (the Extraordinary General Meeting).

Key Points: 
  • Bridgetown 2 recommends its shareholders vote in favor of the proposed business combination and the related proposals described in the Companys definitive proxy statement dated February 14, 2022 contained in the Registration Statement (the Proxy Statement), at Bridgetown 2s Extraordinary General Meeting (the Extraordinary General Meeting).
  • If you are a holder of record of Bridgetown 2 shares on the record date, you may vote in person or remotely at the Extraordinary General Meeting or by submitting a proxy card in advance for the Extraordinary General Meeting.
  • The Extraordinary General Meeting will be held at 10:00 a.m. Eastern Time, on March 15, 2022 virtually via live webcast at https://www.cstproxy.com/bridgetown2holdings/2022 .
  • You may attend the Extraordinary General Meeting online, vote and submit your questions during the Extraordinary General Meeting by visiting https://www.cstproxy.com/bridgetown2holdings/2022 and entering the control number on your proxy card.

REZI Signs Deal for 70 Luxury Apartments at Archer House with Partners ZD Jasper & Century Group Development

Retrieved on: 
Monday, February 7, 2022
Pacific Century Group, Dar Al Arkan Real Estate Development Company, MWBE, Marketing, Game Room, Heart, Technology, JumpStart 3D Virtual World, Integrity, Health, Lease, Archer House Hotel

NEW YORK, Feb. 7, 2022 /PRNewswire/ -- REZI , the pioneer of Occupancy-as-a-Service, has closed a five-year deal withrespected developers, ZD Jasper and Century Group Development, for Archer House , the new luxury development in Jamaica, Queens.

Key Points: 
  • NEW YORK, Feb. 7, 2022 /PRNewswire/ -- REZI , the pioneer of Occupancy-as-a-Service, has closed a five-year deal withrespected developers, ZD Jasper and Century Group Development, for Archer House , the new luxury development in Jamaica, Queens.
  • This deal contracts 70 apartments directly to REZI to manage all sales, marketing, and leasing activities.
  • REZI will be providing their proprietary AI-powered service that enables landlords to lease their residential properties directly to REZI with guaranteed income.
  • "Archer House is an incredible asset and our partners at ZD Jasper and Century Group Development have been nothing short of outstanding," said Smith.

22nd Century Group to Announce Fourth Quarter and Full Year 2021 Results on March 1, 2022

Retrieved on: 
Thursday, February 3, 2022
Webcast, Forward-looking statement, RNC, Century, Nicotine, XXII, Plant, Nasdaq, Death, Investor relations, Disease, R. J. Reynolds Tobacco Company, Pacific Century Group, Company, MRTP, Health, Tobacco, Q&A, Genetic engineering, GLOBE, Media, FDA, Smoking, Solution, Software, Public relations

22nd Century will report the Companys fourth quarter and full year 2021 results in a press release at 6:00 AM ET the same day.

Key Points: 
  • 22nd Century will report the Companys fourth quarter and full year 2021 results in a press release at 6:00 AM ET the same day.
  • Following prepared remarks by management and slide presentation, the Company will host a Q&A session, during which management will accept questions from interested analysts.
  • 22nd Century Group, Inc. (Nasdaq: XXII ) is a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science.
  • The Company received the first and only FDA MRTP authorization of a combustible cigarette in December 2021.

22nd Century Group Supports Upcoming FDA Action Banning Menthol in Highly Addictive Combustible Cigarettes

Retrieved on: 
Tuesday, February 1, 2022
Smoke, Forward-looking statement, RNC, Century, Nicotine, Policy, XXII, Plant, Death, Emphasis, Disease, Â, Pacific Century Group, Company, MRTP, Health, Tobacco, Genetic engineering, GLOBE, Science, Smoking, Media, FDA, Smokeless tobacco, Solution, Nasdaq

On January 27, 2022, the FDA posted an update on its FDA Voices site stating that it remains on track with its plans to prohibit menthol in combustible tobacco products.

Key Points: 
  • On January 27, 2022, the FDA posted an update on its FDA Voices site stating that it remains on track with its plans to prohibit menthol in combustible tobacco products.
  • We fully support the FDA taking action on menthol cigarettes, in particular due to the disproportionate impact highly addictive traditional menthol cigarettes have on minority communities, said James A. Mish, Chief Executive Officer.
  • Maintaining access to a non-addictive menthol cigarette such as VLN Menthol King that Helps You Smoke Less is a critical off-ramp for current menthol smokers.
  • By providing a non-addictive menthol option, we believe FDAs policy can help menthol smokers truly move away from addictive nicotine products rather than merely transitioning to another addictive combustible cigarette or nicotine product, continued Mish.

22nd Century Group Announces First Production of VLN® Cigarettes for Retail Sale

Retrieved on: 
Wednesday, January 26, 2022
Smoke, Century, Nasdaq, Solution, Adult, Forward-looking statement, RNC, Tobacco, Smoker, Pacific Century Group, Nicotine, Health, Sale, MRTP, Media, Smoking, Genetic engineering, Disease, Company, Plant, Smokeless tobacco, Death, XXII, GLOBE, FDA, Operation

Since receiving the first and only FDA MRTP designation for a combustible cigarette on December 23, we have moved swiftly to prepare the launch of our VLN 95% reduced nicotine content cigarettes.

Key Points: 
  • Since receiving the first and only FDA MRTP designation for a combustible cigarette on December 23, we have moved swiftly to prepare the launch of our VLN 95% reduced nicotine content cigarettes.
  • Production of VLN for commercial sale is now underway at 22nd Centurys in-house manufacturing facilities, said Nathan Schmitt, Director of Operations & Supply Chain.
  • VLN King and VLN Menthol King are the only FDA authorized reduced nicotine content combustible cigarettes in the U.S. tobacco products market, estimated at approximately $80 billion in size.
  • 22nd Century Group, Inc. (Nasdaq: XXII ) is a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science.

22nd Century Group Appoints James A. Mish to Its Board of Directors

Retrieved on: 
Friday, January 21, 2022
Century, MRTP, European Medicines Agency, Forward-looking statement, Genetic engineering, Research, Plant, Nicotine, Tobacco, RNC, European Food Safety Authority, EMA, Regulation of tobacco by the U.S. Food and Drug Administration, Pacific Century Group, List of tobacco products, Pfizer, Death, Disease, Solution, EFSA, Smokeless tobacco, GLOBE, Health, API, Media, Nasdaq, OTC, XXII, Smoking, Company, Food, FDA, Director, Board, Fine chemical, Johnson & Johnson

BUFFALO, N.Y, Jan. 21, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through modern plant science, today announced the appointment of James A. Mish to its Board of Directors (Board).

Key Points: 
  • BUFFALO, N.Y, Jan. 21, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through modern plant science, today announced the appointment of James A. Mish to its Board of Directors (Board).
  • Trained as a chemist, Mr. Mish brings a detailed understanding of molecular, organic and formulation sciences to the Board particularly in botanical products and consumer product innovation.
  • Prior to joining 22nd Century, Mr. Mish led the private equity carve out of Noramco from Johnson & Johnson/Janssen Pharmaceuticals and the subsequent spinoff of Purisys from Noramco.
  • 22nd Century Group, Inc. (Nasdaq: XXII ) is a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science.

22nd Century Launching the First Reduced Nicotine Cigarette Authorized by the FDA That Helps You Smoke Less

Retrieved on: 
Tuesday, January 18, 2022
Smoke, Century, MRTP, Research, Genetic engineering, Forward-looking statement, Nicotine, Technology, Plant, RNC, Smoker, Death, Adult, Pacific Century Group, Disease, Solution, GLOBE, Smokeless tobacco, Public health, Health, Media, Nasdaq, XXII, Smoking, Marketing, Company, Sale, FDA, Tobacco, Risk management, Dietary supplement

Scientific studies show the Companys VLN reduced nicotine content cigarettes help you smoke less.

Key Points: 
  • Scientific studies show the Companys VLN reduced nicotine content cigarettes help you smoke less.
  • The FDA decision on VLN is a major event for public health in the fight to reduce the harm caused by smoking.
  • VLN King and VLN Menthol King are the only FDA authorized reduced nicotine content combustible cigarettes in the U.S. tobacco products market, estimated at approximately $80 billion in size.
  • 22nd Century Group, Inc. (Nasdaq: XXII ) is a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science.